Acid, Hyaluronic, Intraarticular
Main Filters
Acid, Hyaluronic, Intraarticular
9902392 Canada Inc | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
024 | 0 | - |
ALLY MEDICAL SUPPLIES LTD | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
None | 0 | - | ||
None | 0 | - |
Anika Therapeutics, Inc. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
630254 | 0 | - | ||
690016 | 0 | - |
Arcera GmbH | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
n/a | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - | ||
N/A | 0 | - |
ARTHREX, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
82197-0721-16 | 0 | - |
BIOVENTUS LLC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
1082020 | 0 | - |
EAGLE SPRINGS ENTERPRISES LLC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
Hylan GF-20 | 0 | - | ||
Hylan GF-20 | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - | ||
NA | 0 | - |
FCL HEALTH SOLUTIONS LTD | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
NA | 0 | - | ||
NA | 0 | - |
GENZYME CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
002390 | 0 | - |
ORTHOGENRX, INC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
50653-0006-01 | 0 | - | ||
50653-0006-04 | 0 | - |
SEIKAGAKU CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
00-1111-001-00 | 0 | - | ||
00-1111-001-00 | 0 | - | ||
00-1111-001-03 | 0 | - |
TEVA PHARMACEUTICALS USA, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
57844-181 | 0 | - |
79 Results
Results Per Page
- 50
- 100
- 250
Catalog #
Available
Starting At
Name
Company Name
Description
0
-
VISCO-3 sodium hyaluronate
SEIKAGAKU CORPORATION
VISCO-3 (P980044/S027) is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.VISCO-3 is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) (620 000-1 170 000 daltons). HA, which is extracted from chicken combs, is a polysaccharide containing repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is a common constituent of the extracellular matrix of connective tissues. VISCO-3 is supplied sterile in single-use, pre-filled, disposable plastic syringes, each containing 25 mg of HA dissolved in a Phosphate Buffered Saline (PBS) solution (2.5 mL of 1.0% solution).
0
-
Gel-One® Cross-linked Hyaluronate
SEIKAGAKU CORPORATION
Gel-One is a cross-linked hyaluronate hydrogel that is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics (e.g., acetaminophen). Gel-One is physician-administered, and is injected directly into the cavity of the knee joint. It is delivered via a single-use, pre-filled disposable glass syringe containing 3 mL of Gel-One.
0
-
TriVisc™ sodium hyaluronate
ORTHOGENRX, INC
TriVisc™ 850 sodium hyaluronate (P160057) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. TriVisc is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) with an average molecular weight of 850,000 daltons and a range of 620,000 – 1,170,000 daltons). The HA is a polymer of repeating disaccharide units of glucuronic acid and N-acetyl-glucosamine derived from a bacterial fermentation process. TriVisc is supplied in a prefilled syringe containing 25 mg of HA in 2.5 mL of physiological saline solution (1% solution).
0
-
GenVisc® 850 sodium hyaluronate
ORTHOGENRX, INC
GenVisc® 850 sodium hyaluronate (P140005) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. GenVisc 850 is a sterile, viscoelastic, non-pyrogenic solution (pH of 6.8-7.8) of highly purified, high molecular weight hyaluronic acid (HA) with an average molecular weight of 850,000 daltons and a range of 620,000 – 1,170,000 daltons). The HA is a polymer of repeating disaccharide units of glucuronic acid and N-acetyl-glucosamine derived from a bacterial fermentation process. GenVisc 850 is supplied in a prefilled syringe containing 25 mg of HA in 2.5 mL of physiological saline solution (1% solution).
0
-
DUROLANE
BIOVENTUS LLC
DUROLANE is a clear, transparent, viscous gel of highly purified, stabilized, non-animal-derived sodium hyaluronate that is biosynthesized using bacterial fermentation. NASHA® technology is used to stabilize naturally entangled hyaluronic acid (HA) chains to produce a gel. The gel is suspended in phosphate-buffered saline at a concentration of 20 mg/mL. DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.
0
-
Gel-One® Cross-linked Hyaluronate
SEIKAGAKU CORPORATION
Gel-One is a cross-linked hyaluronate hydrogel that is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics (e.g., acetaminophen). Gel-One is physician-administered, and is injected directly into the cavity of the knee joint. It is delivered via a single-use, pre-filled disposable glass syringe containing 3 mL of Gel-One.
- 1
- 2